Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013		Mar. 31, 2012
Revenues:
Product sales	$ 1,116.7		$ 1,106.9
Royalties	38.5		56.3
Other revenues	6.7		8.6
Total revenues	1,161.9		1,171.8
Costs and expenses:
Cost of product sales	155.9	[1]	158.4	[1]
Research and development	224.2	[1]	220.3	[1]
Selling, general and administrative	438.7	[1]	500.0	[1]
Goodwill Impairment charge	198.9		0
Gain on sale of product rights	(6.5)		(7.2)
Reorganization costs	17.5		0
Integration and acquisition costs	4.1		5.3
Total operating expenses	1,032.8		876.8
Operating income	129.1		295.0
Interest income	0.7		0.8
Interest expense	(9.1)		(10.2)
Other (expense)/ income, net	(1.1)		1.9
Total other expense, net	(9.5)		(7.5)
Income before income taxes and equity in earnings of equity method investees	119.6		287.5
Income taxes	(55.2)		(50.0)
Equity in earnings of equity method investees, net of taxes	0.4		0.9
Net income	$ 64.8		$ 238.4
Earnings per ordinary share - basic	$ 0.117		$ 0.431
Earnings per ordinary share - diluted	$ 0.117		$ 0.414
Weighted average number of shares:
Basic	551.5	[2]	553.5	[2]
Diluted	555.3		595.6

[1] Cost of product sales includes amortization of intangible assets relating to favorable manufacturing contracts of $nil for the three months to March 31, 2013 (2012: $0.2 million). SG&A costs includes amortization of intangible assets relating to intellectual property rights acquired of $45.9 million for the three months to March 31, 2013 (2012: $45.6 million).

[2] Excludes shares purchased by the EBT and under the share buy-back program and presented by Shire as treasury stock.